Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Net Income (2019 - 2025)

Biodesix's Net Income history spans 7 years, with the latest figure at -$4.0 million for Q4 2025.

  • For Q4 2025, Net Income rose 52.08% year-over-year to -$4.0 million; the TTM value through Dec 2025 reached -$35.6 million, up 16.76%, while the annual FY2025 figure was -$35.6 million, 16.76% up from the prior year.
  • Net Income reached -$4.0 million in Q4 2025 per BDSX's latest filing, up from -$9.1 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$4.0 million in Q4 2025 to a low of -$18.8 million in Q1 2023.
  • Average Net Income over 5 years is -$11.7 million, with a median of -$11.5 million recorded in 2021.
  • Peak YoY movement for Net Income: crashed 292.35% in 2021, then soared 52.08% in 2025.
  • A 5-year view of Net Income shows it stood at -$13.2 million in 2021, then fell by 24.78% to -$16.4 million in 2022, then surged by 44.05% to -$9.2 million in 2023, then grew by 8.67% to -$8.4 million in 2024, then skyrocketed by 52.08% to -$4.0 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Net Income are -$4.0 million (Q4 2025), -$9.1 million (Q3 2025), and -$11.6 million (Q2 2025).